Blood biomarkers and Ki-67 proliferation marker in breast cancer
Metastasis is the leading cause of death in patients with breast cancer (BC). It is known that the lesion of regional lymph nodes by tumor cells is more common in tumors with higher proliferative activity. Moreover, there is literature evidence on effects of cytokines and proteins upon the migration...
Hlavní autoři: | A. A. Studenikina, E. S. Mikhaylova, S. A. Arkhipov, N. A. Varaksin, A. V. Proskura, A. I. Autenshlyus |
---|---|
Médium: | Článek |
Jazyk: | Russian |
Vydáno: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2023-04-01
|
Edice: | Медицинская иммунология |
Témata: | |
On-line přístup: | https://www.mimmun.ru/mimmun/article/view/2570 |
Podobné jednotky
-
Ki-67 evaluation in breast cancer: The daily diagnostic practice
Autor: Lukasz Fulawka, a další
Vydáno: (2017-01-01) -
Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
Autor: Fatima S. Al-Sarraf, a další
Vydáno: (2015-07-01) -
The cell proliferation antigen Ki-67 organises heterochromatin
Autor: Michal Sobecki, a další
Vydáno: (2016-03-01) -
Ki-67 protein: a proliferation index in breast cancer
Autor: Shervin Kheirandish, a další
Vydáno: (2015-10-01) -
Ki-67 protein: a proliferation index in breast cancer
Autor: Shervin Kheirandish, a další
Vydáno: (2015-09-01)